AB Science Share Price

Equities

AB

FR0010557264

Pharmaceuticals

Market Closed - Euronext Paris 09:05:15 26/04/2024 pm IST 5-day change 1st Jan Change
1.936 EUR +2.76% Intraday chart for AB Science -1.63% -45.54%

Financials

Sales 2023 * 930K 994K 82.94M Sales 2024 * 990K 1.06M 88.29M Capitalization 98.86M 106M 8.82B
Net income 2023 * -19M -20.32M -1.69B Net income 2024 * -18M -19.25M -1.61B EV / Sales 2023 * 106 x
Net cash position 2023 * - 0 0 Net cash position 2024 * - 0 0 EV / Sales 2024 * 99.9 x
P/E ratio 2023 *
-5.09 x
P/E ratio 2024 *
-5.38 x
Employees 89
Yield 2023 *
-
Yield 2024 *
-
Free-Float 66.05%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on AB Science

1 day+2.76%
1 week-1.63%
Current month-23.48%
1 month-24.52%
3 months-49.71%
6 months-15.46%
Current year-45.54%
More quotes
1 week
1.88
Extreme 1.884
2.03
1 month
1.88
Extreme 1.884
2.53
Current year
1.55
Extreme 1.55
4.47
1 year
1.55
Extreme 1.55
6.26
3 years
1.55
Extreme 1.55
16.68
5 years
1.55
Extreme 1.55
21.75
10 years
1.55
Extreme 1.55
21.75
More quotes
Managers TitleAgeSince
Chief Executive Officer - 11/01/11
Director of Finance/CFO - 01/02/01
Chief Tech/Sci/R&D Officer - 01/18/01
Members of the board TitleAgeSince
Chief Executive Officer - 11/01/11
Director/Board Member - 11/01/11
Director/Board Member 62 27/21/27
More insiders
Date Price Change Volume
26/24/26 1.936 +2.76% 32,531
25/24/25 1.884 -2.89% 71,388
24/24/24 1.94 -2.02% 68,439
23/24/23 1.98 -0.90% 57,815
22/24/22 1.998 +1.52% 75,972

Real-time Euronext Paris, April 26, 2024 at 09:05 pm IST

More quotes
AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.936 EUR
Average target price
6.895 EUR
Spread / Average Target
+256.15%
Consensus

Annual profits - Rate of surprise